Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7971977 | 1.00 | HSD17B10 (0.35) | HSD17B10MAPTMAPK1TSHR | |
| SCHEMBL27383307 | 1.00 | HSD17B10 (0.35) | HSD17B10MAPTMAPK1TSHR | |
| SCHEMBL11504980 | 0.87 | — | — | |
| SCHEMBL25896811 | 0.87 | — | — | |
| SCHEMBL18308874 | 0.87 | — | — | |
| SCHEMBL347219 | 0.87 | — | — | |
| SCHEMBL12015851 | 0.87 | — | — | |
| SCHEMBL12755542 | 0.86 | MAPT (0.35) | HSD17B10MAPT | |
| SCHEMBL14982784 | 0.86 | — | — | |
| SCHEMBL8041418 | 0.86 | LMNA (0.37) | HSD17B10MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3846691-A2 | SYSTEM FOR DETECTION OF VOLATILE ORGANIC COMPOUNDS (VOC) IN EXHALED BREATH FOR HEALTH MONITORING | Kozhnosys Private Limited (IN) | 2021-07-14 | — | — | EP | claimed |
| US-20210186367-A1 | SYSTEM FOR DETECTION OF VOLATILE ORGANIC COMPOUNDS (VOC) IN EXHALED BREATH FOR HEALTH MONITORING | KOZHNOSYS PRIVATE LIMITED (IN) | 2021-06-24 | — | — | US | claimed |
| US-20240225477-A9 | SYSTEM FOR DETECTION OF VOLATILE ORGANIC COMPOUNDS (VOC) IN EXHALED BREATH FOR HEALTH MONITORING | KOZHNOSYS PRIVATE LIMITED (IN) | 2024-07-11 | — | — | US | disclosed |
| US-20240206762-A1 | SYSTEM FOR DETECTION OF VOLATILE ORGANIC COMPOUNDS (VOC) IN EXHALED BREATH FOR HEALTH MONITORING | KOZHNOSYS PRIVATE LIMITED (IN) | 2024-06-27 | — | — | US | disclosed |
| US-20240130632-A1 | SYSTEM FOR DETECTION OF VOLATILE ORGANIC COMPOUNDS (VOC) IN EXHALED BREATH FOR HEALTH MONITORING | KOZHNOSYS PRIVATE LTD (IN) | 2024-04-25 | — | — | US | disclosed |
| US-20230212667-A1 | METHODS OF NUCLEIC ACID SEQUENCING USING SURFACE-BOUND PRIMERS | ILLUMINA CAMBRIDGE LIMITED (GB) | 2023-07-06 | — | — | US | disclosed |
| EP-3846691-A2 | SYSTEM FOR DETECTION OF VOLATILE ORGANIC COMPOUNDS (VOC) IN EXHALED BREATH FOR HEALTH MONITORING | Kozhnosys Private Limited (IN) | 2021-07-14 | — | — | EP | disclosed |
| US-20210186367-A1 | SYSTEM FOR DETECTION OF VOLATILE ORGANIC COMPOUNDS (VOC) IN EXHALED BREATH FOR HEALTH MONITORING | KOZHNOSYS PRIVATE LIMITED (IN) | 2021-06-24 | — | — | US | disclosed |
| CN-104447443-B | A kind of Apremilast and the preparation method of intermediate thereof | 新发药业有限公司 | 2016-07-27 | — | — | CN | disclosed |
| EP-2319855-B1 | Bioconjugation of Macromolecules | SIGMA ALDRICH CO LLC (US) | 2016-04-06 | — | — | EP | disclosed |
| US-20080287695-A1 | Agent For Optical Resolution, Process For Producing Optically Active Substance and 1,5-Substituted Bicyclo [3.3.0] -2-Oxaoctane Compound | ZEON CORPORATION (JP) | 2008-11-20 | — | — | US | disclosed |
| EP-1719746-A1 | OPTICAL RESOLVER, PROCESS FOR PRODUCING OPTICALLY ACTIVE ISOMER, AND 1,5-SUBSTITUTED BICYCLO (3.3.0) -2-OXAOCTANE COMPOUND | ZEON CORPORATION (JP) | 2006-11-08 | — | — | EP | disclosed |
| EP-1117636-B1 | METHOD FOR PREPARING TRION-BIS(OXIME ETHER) DERIVATIVES ANDRION-MONO AND TRION-BIS(OXIME ETHER) DERIVATIVES OBTAINED THEREWITH | BASF AG (DE) | 2002-12-11 | — | — | EP | disclosed |
| US-6441236-B1 | HYDROLYSIS, AMINATION | BASF AKTIENGESELLSCHAFT (DE) | 2002-08-27 | — | — | US | disclosed |
| US-6274303-B1 | INCLUDES PERFUSION OF TISSUE WITH INERT FLUIDS THAT REMAIN LIQUID AT VERY LOW TEMPERATURES SUCH AS SILICONES, OR FLUOROSILICONES | WOWK BRIAN G (CA) | 2001-08-14 | — | — | US | disclosed |
| EP-1117636-A1 | METHOD FOR PREPARING TRION-BIS(OXIME ETHER) DERIVATIVES ANDRION-MONO AND TRION-BIS(OXIME ETHER) DERIVATIVES OBTAINED THEREWITH | BASF AKTIENGESELLSCHAFT (DE) | 2001-07-25 | — | — | EP | disclosed |
| WO-2000018726-A1 | METHOD FOR PREPARING TRION-BIS(OXIME ETHER) DERIVATIVES ANDRION-MONO AND TRION-BIS(OXIME ETHER) DERIVATIVES OBTAINED THEREWITH | BASF AKTIENGESELLSCHAFT (DE) | 2000-04-06 | — | — | WO | disclosed |
| US-5952168-A | ADMINISTERING CRYOPROTECTIVE AGENT MIXTURE, THEN COOLING MATERIAL; FOR UNIFORM COOLING OF ORGANS AND ANIMALS | 21ST CENTURY MEDICINE, INC. (US) | 1999-09-14 | — | — | US | disclosed |
| WO-1998019529-A1 | A METHOD FOR RAPID COOLING AND WARMING OF BIOLOGICAL MATERIALS | 21ST CENTURY MEDICINE, INC. (US) | 1998-05-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080287695-A1 | Agent For Optical Resolution, Process For Producing Optically Active Substance and 1,5-Substituted Bicyclo [3.3.0] -2-Oxaoctane Compound | ALDH1A2, OXER1, HCRTR1 | HSD17B10 2517/4885MAPT 3787/4885MAPK1 1042/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.